"approved"@en . . "U.S. Patents 3,177,252; 3,219,528; and 3,357,978."@en . . . "Bromoprid"@en . "4093-35-0"@en . "Bromopride"@en . "Bromopride is a dopamine antagonist with prokinetic properties closely related to metoclopramide, and is widely used as an antiemetic. It is not available in the United States or the United Kingdom."@en . . "Bromoprida"@en . . . "4-amino-5-bromo-N-[2-(diethylamino)ethyl]-2-methoxybenzamide"@en . "Bromopride"@en . . . . "Bromopridum"@en . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "40%."@en . "Bromopride in indicated in the treatment of nausea and vomiting, including PONV (post-operative nausea and vomiting), gastroesophageal reflux disease (GERD/GORD), as well as endoscopy preparation and radiographic studies of the GI tract. "@en . "Renal, 10-14% as original compound. "@en .